Discovery 2 X-MAN™
 |
| Discovery 2 lines encompass ‘gain-of-function’ models generated via the double knock-in of mutated cancer genes. These models accurately recapitulate known resistance mechanisms that lead to certain patient populations being unresponsive to marketed cancer drugs. |
Horizon X-MAN Catalogue
Issue: Q4, 2011
Click here to view/download
Call us today on +44 (0) 1223 655580 or email us at xman@horizondiscovery.com to discuss how X-MAN products and services can target your specific research needs.
